Yeda Research and Development

Dr. Elik Chapnik is a technology transfer and innovation leader with a strong scientific background and extensive experience across scientific research, drug development, and commercialization. He currently serves as CEO of Yeda, the technology transfer company of the Weizmann Institute of Science, where he leads efforts to translate scientific discoveries into real-world impact through licensing, industry collaborations, and venture creation.

Previously, Elik served as VP of Business Development at Yeda, responsible for commercializing life science technologies and forging partnerships across pharma, biotech, and deep tech. Before joining Yeda, he held senior roles at Quark Pharmaceuticals and Teva Pharmaceuticals, managing early clinical development, translational research, and precision medicine programs. Elik holds a Ph.D. in Molecular Genetics and an M.Sc. in Developmental Biology from the Weizmann Institute.

With a unique blend of scientific expertise, strategic vision, and operational leadership, Elik helps drive forward Weizmann’s mission of advancing science for the benefit of humanity.